Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 9

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

DexDesign: an OSPREY-based algorithm for designing de novo D-peptide inhibitors

Guerin, Nathan, Childs, Henry, Zhou, Pei, Donald, Bruce R · 2024 · Protein Engineering, Design and Selection

Abstract

With over 270 unique occurrences in the human genome, peptide-recognizing PDZ domains play a central role in modulating polarization, signaling, and trafficking pathways. Mutations in PDZ domains lead to diseases such as cancer and cystic fibrosis, making PDZ domains attractive targets for therapeutic intervention. D-peptide inhibitors offer unique advantages as therapeutics, including increased metabolic stability and low immunogenicity. Here, we introduce DexDesign, a novel OSPREY-based algorithm for computationally designing de novo D-peptide inhibitors. DexDesign leverages three novel techniques that are broadly applicable to computational protein design: the Minimum Flexible Set, K*-based Mutational Scan, and Inverse Alanine Scan. We apply these techniques and DexDesign to generate novel D-peptide inhibitors of two biomedically important PDZ domain targets: CAL and MAST2. We introduce a framework for analyzing de novo peptides—evaluation along a replication/restitution axis—and apply it to the DexDesign-generated D-peptides. Notably, the peptides we generated are predicted to bind their targets tighter than their targets' endogenous ligands, validating the peptides' potential as lead inhibitors. We also provide an implementation of DexDesign in the free and open source computational protein design software OSPREY.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/protein/gzae007

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 100

  1. Amacher, 2013, Stereochemical determinants of C-terminal specificity in PDZ peptide-binding domains, J Biol Chem, 288, 5114, 10.1074/jbc.M112.401588 · DOI
  2. Amacher, 2020, Specificity in PDZ-peptide interaction networks: computational analysis and review, J Struct Biol, 4, 100022
  3. Angelini, 2012, Bicyclic peptide inhibitor reveals large contact Interface with a protease target, ACS Chem Biol, 7, 817, 10.1021/cb200478t · DOI · Paper page
  4. Banting, 2024, Nobel Prize Outreach AB 2023
  5. Berman, 2000, The protein data Bank, Nucleic Acids Res, 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
  6. Bhardwaj, 2016, Accurate de novo design of hyperstable constrained peptides, Nature, 538, 329, 10.1038/nature19791 · DOI · Paper page
  7. Brower, 1985, Immunodetection with streptavidin-acid phosphatase complex on western blots, Anal Biochem, 147, 382, 10.1016/0003-2697(85)90286-6 · doi:10.1016/0003-2697(85)90286-6
  8. Caillet-Saguy, 2015, Strategies to interfere with PDZ-mediated interactions in neurons: what we can learn from the rabies virus, Prog Biophys Mol Biol, 119, 53, 10.1016/j.pbiomolbio.2015.02.007 · DOI
  9. Case, 2022, Amber 2022
  10. Case, 2023, AmberTools, J Chem Inf Model, 63, 6183, 10.1021/acs.jcim.3c01153 · DOI · Paper page
  11. Chen, 2013, Improving binding affinity and stability of peptide ligands by substituting Glycines with D-amino acids, Chembiochem, 14, 1316, 10.1002/cbic.201300228 · DOI
  12. Christensen, 2019, PDZ domains as drug targets, Adv Ther (Weinh), 2, 1800143, 10.1002/adtp.201800143 · DOI
  13. Cielo, 2010, Structure of ST0929, a putative glycosyl transferase from Sulfolobus tokodaii, Acta Crystallogr Sect F Struct Biol Cryst Commun, 66, 397, 10.1107/S1744309110006354 · doi:10.1107/s1744309110006354
  14. Craik, 2013, The future of peptide-based drugs, Chem Biol Drug Des, 81, 136, 10.1111/cbdd.12055 · DOI · Paper page
  15. Dahiyat, 1997, De novo protein design: fully automated sequence selection, Science, 278, 82, 10.1126/science.278.5335.82 · DOI · Paper page
  16. Davey, 2011, How viruses hijack cell regulation, Trends Biochem Sci, 36, 159, 10.1016/j.tibs.2010.10.002 · DOI · Paper page
  17. Delhommel, 2015, Deciphering the unconventional peptide binding to the PDZ domain of MAST2, Biochem J, 469, 159, 10.1042/BJ20141198 · DOI
  18. Donald, 2011, Algorithms in Structural Molecular Biology
  19. Doti, 2021, Recent applications of retro-Inverso peptides, Int J Mol Sci, 22, 8677, 10.3390/ijms22168677 · DOI
  20. Dougherty, 2020, Cyclic peptidyl inhibitors against CAL/CFTR interaction for treatment of cystic fibrosis, J Med Chem, 63, 15773, 10.1021/acs.jmedchem.0c01528 · DOI
  21. Doyle, 1996, Crystal structures of a complexed and peptide-free membrane protein-binding domain: molecular basis of peptide recognition by PDZ, Cell, 85, 1067, 10.1016/S0092-8674(00)81307-0 · DOI · Paper page
  22. Elkin, 2000, Computational design of D-peptide inhibitors of hepatitis delta antigen dimerization, J Comput Aided Mol Des, 14, 705, 10.1023/A:1008146015629 · DOI
  23. Fosgerau, 2015, Peptide therapeutics: current status and future directions, Drug Discov Today, 20, 122, 10.1016/j.drudis.2014.10.003 · DOI · Paper page
  24. Freitag, 1997, Structural studies of the streptavidin binding loop, Protein Sci, 6, 1157, 10.1002/pro.5560060604 · DOI
  25. Freitag, 1999, X-ray crystallographic studies of streptavidin mutants binding to biotin, Biomol Eng, 16, 13, 10.1016/S1050-3862(99)00048-0 · doi:10.1016/s1050-3862(99)00048-0
  26. Frey, 2010, Predicting resistance mutations using protein design algorithms, Proc Natl Acad Sci, 107, 13707, 10.1073/pnas.1002162107 · DOI
  27. Gainza, 2012, Protein design using continuous rotamers, PLoS Comput Biol, 8, e1002335, 10.1371/journal.pcbi.1002335 · DOI
  28. Garton, 2017, A computational approach for designing D-proteins with non-canonical amino acid optimised binding affinity, PloS One, 12, e0187524, 10.1371/journal.pone.0187524 · DOI
  29. Garton, 2018, Method to generate highly stable D-amino acid analogs of bioactive helical peptides using a mirror image of the entire PDB, Proc Natl Acad Sci, 115, 1505, 10.1073/pnas.1711837115 · DOI
  30. Georgiev, 2009, OSPREY User Manual v1.0
  31. Georgiev, 2008, The minimized dead-end elimination criterion and its application to protein redesign in a hybrid scoring and search algorithm for computing partition functions over molecular ensembles, J Comput Chem, 29, 1527, 10.1002/jcc.20909 · DOI
  32. Guerin, 2022, Resistor: an algorithm for predicting resistance mutations via Pareto optimization over multistate protein design and mutational signatures, Cell Systems, 13, 830, 10.1016/j.cels.2022.09.003 · DOI
  33. Guerin, 2023, Protocol for predicting drug-resistant protein mutations to an ERK2 inhibitor using RESISTOR, STAR Protocols, 4, 102170, 10.1016/j.xpro.2023.102170 · DOI
  34. Hallen, 2017, CATS (coordinates of atoms by Taylor series): protein design with backbone flexibility in all locally feasible directions, Bioinformatics, 33, i5, 10.1093/bioinformatics/btx277 · DOI
  35. Hallen, 2018, OSPREY 3.0: open-source protein redesign for you, with powerful new features, J Comput Chem, 39, 2494, 10.1002/jcc.25522 · DOI · Paper page
  36. Harris, 2001, Mechanism and role of PDZ domains in signaling complex assembly, J Cell Sci, 114, 3219, 10.1242/jcs.114.18.3219 · DOI · Paper page
  37. Haugaard-Kedström, 2021, A high-affinity peptide ligand targeting Syntenin inhibits glioblastoma, J Med Chem, 64, 1423, 10.1021/acs.jmedchem.0c00382 · DOI
  38. Holt, 2019, Computational analysis of energy landscapes reveals dynamic features that contribute to binding of inhibitors to CFTR-associated ligand, J Phys Chem B, 123, 10441, 10.1021/acs.jpcb.9b07278 · DOI
  39. Holt, 2023, Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico design, Cell Rep, 42, 112711, 10.1016/j.celrep.2023.112711 · DOI
  40. Hyre, 2006, Cooperative hydrogen bond interactions in the streptavidin–biotin system, Protein Sci, 15, 459, 10.1110/ps.051970306 · doi:10.1110/ps.051970306
  41. Ivarsson, 2012, Plasticity of PDZ domains in ligand recognition and signaling, FEBS Lett, 586, 2638, 10.1016/j.febslet.2012.04.015 · DOI
  42. Jemth, 2007, PDZ domains: folding and binding, Biochemistry, 46, 8701, 10.1021/bi7008618 · DOI · Paper page
  43. Jou, 2020, Minimization-aware recursive K*: a novel, provable algorithm that accelerates ensemble-based protein design and provably approximates the energy landscape, J Comput Biol, 27, 550, 10.1089/cmb.2019.0315 · DOI
  44. Jou, 2023, Protein Design Plugin
  45. Jou, 2024, Protein Design Plugin
  46. Kaserer, 2018, Combining mutational signatures, clonal fitness, and drug affinity to define drug-specific resistance mutations in cancer, Cell Chem Biol, 25, 1359, 10.1016/j.chembiol.2018.07.013 · DOI
  47. Khan, 2019, Structure-based optimization of a PDZ-binding motif within a viral peptide stimulates neurite outgrowth, J Biol Chem, 294, 13755, 10.1074/jbc.RA119.008238 · DOI
  48. Kugler, 2023, Disruptor: computational identification of oncogenic mutants disrupting protein-protein and protein-DNA interactions, Commun Biol, 6, 1, 10.1038/s42003-023-05089-2 · DOI
  49. Kuhlman, 2000, Native protein sequences are close to optimal for their structures, Proc Natl Acad Sci U S A, 97, 10383, 10.1073/pnas.97.19.10383 · DOI · Paper page
  50. Kuriyan, 2012, The Molecules of Life: Physical and Chemical Principles, 10.1201/9780429258787 · DOI
  51. Lander, 2023, D-peptide and D-protein technology: recent advances, challenges, and opportunities, Chembiochem, 24, e202200537, 10.1002/cbic.202200537 · DOI
  52. Lee, 2010, PDZ domains and their binding partners: structure, specificity, and modification, Cell Commun Signal, 8, 8, 10.1186/1478-811X-8-8 · DOI · Paper page
  53. Lilien, 2005, A novel ensemble-based scoring and search algorithm for protein redesign and its application to modify the substrate specificity of the gramicidin synthetase a phenylalanine adenylation enzyme, J Comput Biol, 12, 740, 10.1089/cmb.2005.12.740 · DOI
  54. Liu, 2010, D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms, Proc Natl Acad Sci U S A, 107, 14321, 10.1073/pnas.1008930107 · DOI · Paper page
  55. Lovell, 2000, The penultimate rotamer library, Proteins, 40, 389, 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2 · DOI · Paper page
  56. Lowegard, 2020, Novel, provable algorithms for efficient ensemble-based computational protein design and their application to the redesign of the c-Raf-RBD:KRas protein-protein interface, PLoS Comput Biol, 16, e1007447, 10.1371/journal.pcbi.1007447 · DOI
  57. Lyamichev, 2017, Stepwise evolution improves identification of diverse peptides binding to a protein target, Sci Rep, 7, 12116, 10.1038/s41598-017-12440-1 · DOI
  58. Martin, 2024, Conformation Energy:: OSPREY
  59. Melero, 2014, Quantification of the transferability of a designed protein specificity switch reveals extensive epistasis in molecular recognition, Proc Natl Acad Sci U S A, 111, 15426, 10.1073/pnas.1410624111 · DOI
  60. Mignon, 2017, Computational design of the Tiam1 PDZ domain and its ligand binding, J Chem Theory Comput, 13, 2271, 10.1021/acs.jctc.6b01255 · DOI
  61. Miles, 2018, Peptide mimic for influenza vaccination using nonnatural combinatorial chemistry, J Clin Invest, 128, 1569, 10.1172/JCI91512 · DOI · Paper page
  62. Miranker, 1991, Functionality maps of binding sites: a multiple copy simultaneous search method, Proteins, 11, 29, 10.1002/prot.340110104 · DOI · Paper page
  63. Nakariyakul, 2014, A sequence-based computational approach to predicting PDZ domain-peptide interactions, Biochim Biophys Acta, 1844, 165, 10.1016/j.bbapap.2013.04.008 · doi:10.1016/j.bbapap.2013.04.008
  64. Nardella, 2021, Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer, Biol Direct, 16, 15, 10.1186/s13062-021-00303-9 · DOI
  65. Noether, 1983, Gesammelte Abhandlungen-Collected Papers, Springer Collected Works in Mathematics, 10.1007/978-3-642-39990-9 · doi:10.1007/978-3-642-39990-9
  66. Oda, 2000, Crystal structure of tobacco necrosis virus at 2.25 Å resolution, J Mol Biol, 300, 153, 10.1006/jmbi.2000.3831 · doi:10.1006/jmbi.2000.3831
  67. Ojewole, 2018, BBK* (branch and bound over K*): a provable and efficient ensemble-based protein design algorithm to optimize stability and binding affinity over large sequence spaces, J Comput Biol, 25, 726, 10.1089/cmb.2017.0267 · DOI
  68. Onufriev, 2019, Generalized born implicit solvent models for biomolecules, Annu Rev Biophys, 48, 275, 10.1146/annurev-biophys-052118-115325 · DOI · Paper page
  69. Opuu, 2020, A physics-based energy function allows the computational redesign of a PDZ domain, Sci Rep, 10, 11150, 10.1038/s41598-020-67972-w · DOI
  70. Panel, 2021, Computational design of PDZ-peptide binding, Methods Mol Biol, 2256, 237, 10.1007/978-1-0716-1166-1_14 · DOI
  71. Piserchio, 2012, PDZ Domain of CAL (Cystic Fibrosis Transmembrane Regulator-Associated Ligand)
  72. Préhaud, 2010, Attenuation of rabies virulence: takeover by the cytoplasmic domain of its envelope protein, Sci Signal, 3, ra5, 10.1126/scisignal.2000510 · DOI
  73. Reeve, 2015, Protein design algorithms predict viable resistance to an experimental antifolate, Proc Natl Acad Sci, 112, 749, 10.1073/pnas.1411548112 · DOI
  74. Reeve, 2019, Toward broad spectrum dihydrofolate reductase inhibitors targeting trimethoprim resistant enzymes identified in clinical isolates of methicillin resistant Staphylococcus aureus, ACS Infect Dis, 5, 1896, 10.1021/acsinfecdis.9b00222 · doi:10.1021/acsinfecdis.9b00222
  75. Renfrew, 2012, Incorporation of noncanonical amino acids into Rosetta and use in computational protein-peptide interface design, PloS One, 7, e32637, 10.1371/journal.pone.0032637 · DOI
  76. Roberts, 2012, Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity, PLoS Comput Biol, 8, e1002477, 10.1371/journal.pcbi.1002477 · DOI
  77. Rudicell, 2014, Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo, J Virol, 88, 12669, 10.1128/JVI.02213-14 · DOI · Paper page
  78. Schrödinger, 2015, The PyMOL Molecular Graphics System, Version 1.8
  79. Skelton, 2003, Origins of PDZ domain ligand specificity: structure determination and mutagenesis of the erbin pdz domain, J Biol Chem, 278, 7645, 10.1074/jbc.M209751200 · DOI
  80. Smith, 2010, Structure-based prediction of the peptide sequence space recognized by natural and synthetic PDZ domains, J Mol Biol, 402, 460, 10.1016/j.jmb.2010.07.032 · DOI
  81. Smith, 2013, Design of a phosphorylatable PDZ domain with peptide-specific affinity changes, Structure, 21, 54, 10.1016/j.str.2012.10.007 · DOI
  82. Stevens, 2006, Redesigning the PheA domain of gramicidin Synthetase leads to a new understanding of the Enzyme’s mechanism and selectivity, Biochemistry, 45, 15495, 10.1021/bi061788m · DOI
  83. Tahti, 2023, Additive energetic contributions of multiple peptide positions determine the relative promiscuity of viral and human sequences for PDZ domain targets, Protein Sci, 32, e4611, 10.1002/pro.4611 · DOI
  84. Terrien, 2010, Solution Structure of MAST2-PDZ Complexed with the C-Terminus of PTEN
  85. Terrien, 2012, Interference with the PTEN-MAST2 interaction by a viral protein leads to cellular relocalization of PTEN, Sci Signal, 5, ra58, 10.1126/scisignal.2002941 · DOI
  86. Valiente, 2021, Computational design of potent D-peptide inhibitors of SARS-CoV-2, J Med Chem, 64, 14955, 10.1021/acs.jmedchem.1c00655 · DOI
  87. Valiente, 2022, Targeting the receptor-binding motif of SARS-CoV-2 with D-peptides mimicking the ACE2 binding helix: lessons for inhibiting omicron and future variants of concern, J Chem Inf Model, 62, 3618, 10.1021/acs.jcim.2c00500 · DOI
  88. Varadi, 2022, AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models, Nucleic Acids Res, 50, D439, 10.1093/nar/gkab1061 · DOI · Paper page
  89. Wang, 2021, Computational Protein Design with Non-proteinogenic Amino Acids and Small Molecule Ligands, with Applications to Protein-Protein Interaction Inhibitors, Anti-Microbial Enzyme Inhibitors, and Antibody Design
  90. Wang, 2007, Identification of a type III thioesterase reveals the function of an operon crucial for Mtb virulence, Chem Biol, 14, 543, 10.1016/j.chembiol.2007.04.005 · DOI
  91. Wang, 2017, D-amino acid-containing supramolecular nanofibers for potential cancer therapeutics, Adv Drug Deliv Rev, 110–111, 102, 10.1016/j.addr.2016.04.008 · DOI
  92. Wang, 2022, Therapeutic peptides: current applications and future directions, Signal Transduct Target Ther, 7, 48, 10.1038/s41392-022-00904-4 · DOI · Paper page
  93. Wang, 2022, Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus, PLoS Comput Biol, 18, e1009855, 10.1371/journal.pcbi.1009855 · DOI
  94. Wei, 2015, A D-peptide ligand of nicotine acetylcholine receptors for brain-targeted drug delivery, Angew Chem Int Ed Engl, 54, 3023, 10.1002/anie.201411226 · DOI · Paper page
  95. Williams, 2018, MolProbity: more and better reference data for improved all-atom structure validation, Protein Sci, 27, 293, 10.1002/pro.3330 · DOI · Paper page
  96. Word, 1999, Visualizing and quantifying molecular goodness-of-fit: small-probe contact dots with explicit hydrogen atoms, J Mol Biol, 285, 1711, 10.1006/jmbi.1998.2400 · DOI · Paper page
  97. Zheng, 2015, Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway, J Mol Biol, 427, 491, 10.1016/j.jmb.2014.10.014 · DOI
  98. Zhou, 2015, Rapid search for tertiary fragments reveals protein sequence–structure relationships, Protein Sci, 24, 508, 10.1002/pro.2610 · DOI
  99. Zhou, 2020, A novel d-peptide identified by mirror-image phage display blocks TIGIT/PVR for cancer immunotherapy, Angew Chem Int Ed Engl, 59, 15114, 10.1002/anie.202002783 · DOI · Paper page
  100. Zhou, 2020, A general-purpose protein design framework based on mining sequence–structure relationships in known protein structures, Proc Natl Acad Sci U S A, 117, 1059, 10.1073/pnas.1908723117 · DOI

Metadata

Authors
Guerin, N., Childs, H., Zhou, P., & Donald, B. R.
Venue
Protein Engineering, Design and Selection
Published
2024
Volume
37
ISSN
  • 1741-0126
  • 1741-0134
Cited by
9
References
4
Language
en
Funders
NIH (R35-GM144042, R01-AI139216)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DexDesign: an OSPREY-based algorithm for designing de novo D-peptide inhibitors. https://app.cochat.ai/papers/10.1093/protein/gzae007
The paper
Guerin, N., Childs, H., Zhou, P., & Donald, B. R. (2024). DexDesign: an OSPREY-based algorithm for designing de novo D-peptide inhibitors. Protein Engineering, Design and Selection. https://doi.org/10.1093/protein/gzae007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.